In The Lancet Oncology, Ajay Aggarwal and colleagues1 apply innovative analytics to study the movement patterns of almost 20 000 patients accessing prostate cancer surgery across the National Health Service (NHS) in England between 2010 and 2014. They find that, in the presence of pressures to centralise surgical services and intense competition, and in the absence of any publicly accessible measure of service quality to allow comparisons, those providers who invest in high tech, in this case robotic, surgery equipment, fare better than those who don't in attracting patients and growing their business.
Original Article: [Comment] Is competition bad for our health(care)? We simply don't know
NEXT ARTICLE